Next Article in Journal / Special Issue
Pharmacist Services in the Opioid Crisis: Current Practices and Scope in the United States
Previous Article in Journal / Special Issue
Clinical Results of Comprehensive Medication Management Services in Primary Care in Belo Horizonte
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle

Systematic Analysis of the Service Process and the Legislative and Regulatory Environment for a Pharmacist-Provided Naltrexone Injection Service in Wisconsin

Sonderegger Research Center, University of Wisconsin School of Pharmacy, Madison, WI 53705, USA
*
Author to whom correspondence should be addressed.
Pharmacy 2019, 7(2), 59; https://doi.org/10.3390/pharmacy7020059
Received: 29 April 2019 / Revised: 31 May 2019 / Accepted: 6 June 2019 / Published: 12 June 2019
(This article belongs to the Special Issue Pharmacist Services)
  |  
PDF [562 KB, uploaded 12 June 2019]
  |     |  

Abstract

Community pharmacists are viewed by the public as convenient and trustworthy sources of healthcare and pharmacists likely can play a larger role in addressing the major public health issue of the opioid epidemic affecting Wisconsin residents. Approved medications, including long-acting injectable naltrexone, can transform the treatment of individuals with opioid use disorder (OUD). Due to shortages of behavioral health providers in the U.S., and pharmacists’ knowledge about the safe use of medications, pharmacists can be a significant access point for treating OUD with naltrexone. Wisconsin’s pharmacy practice laws authorize pharmacists to administer medications via injection, and a small number of pharmacists currently are using this authority to provide a naltrexone injection service. This exploratory study had two objectives: (1) describe the pharmacist injection service process and identify barriers and facilitators to that service and (2) analyze the legislative/regulatory environment to ascertain support for expanding naltrexone injection service. Semi-structured pharmacist interviews (n = 4), and an analysis of Wisconsin statutes/regulations governing public health and social services, were undertaken to explore the objectives. Findings suggest that the service process requires considerable coordination and communication with practitioners, patients, and pharmacy staff, but many opportunities exist to broaden and sustain the service throughout Wisconsin. View Full-Text
Keywords: naltrexone; opioid use disorder; implementation; service process; regulatory; community pharmacy naltrexone; opioid use disorder; implementation; service process; regulatory; community pharmacy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Ford, J.H., II; Gilson, A.; Mott, D.A. Systematic Analysis of the Service Process and the Legislative and Regulatory Environment for a Pharmacist-Provided Naltrexone Injection Service in Wisconsin. Pharmacy 2019, 7, 59.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top